slotkoers
Shenzhen S.E.
00:00:00 06-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,26
CNY
|
-2,29%
|
|
-8,19%
|
-8,58%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
9.229
|
9.781
|
10.969
|
14.335
|
10.098
|
9.226
|
Bedrijfswaarde
1 |
13.792
|
14.713
|
14.981
|
17.280
|
12.453
|
12.242
|
K/w-verhouding
|
18,4
x
|
15,9
x
|
16,8
x
|
21,3
x
|
23,3
x
|
30,5
x
|
Dividendrendement
|
4,77%
|
4,45%
|
3,97%
|
3,04%
|
4,31%
|
4,72%
|
Marktkapitalisatie/omzet
|
0,87
x
|
0,97
x
|
1,01
x
|
1,16
x
|
0,76
x
|
0,8
x
|
Bedrijfswaarde/omzet
|
1,3
x
|
1,46
x
|
1,38
x
|
1,4
x
|
0,94
x
|
1,06
x
|
Bedrijfswaarde/EBITDA
|
6,99
x
|
6,96
x
|
6,91
x
|
7,87
x
|
4,72
x
|
5,67
x
|
Bedrijfswaarde/FCF
|
37
x
|
-213
x
|
16,7
x
|
140
x
|
9,65
x
|
26
x
|
FCF Yield
|
2,7%
|
-0,47%
|
5,98%
|
0,72%
|
10,4%
|
3,85%
|
Price to Book
|
1,02
x
|
1,05
x
|
1,14
x
|
1,42
x
|
0,99
x
|
0,91
x
|
Aantal aandelen (in duizenden)
|
2.001.961
|
1.979.919
|
1.979.919
|
1.979.919
|
1.979.919
|
1.979.919
|
Referentieprijs
2 |
4,610
|
4,940
|
5,540
|
7,240
|
5,100
|
4,660
|
Datum van publicatie
|
10/04/19
|
14/04/20
|
31/03/21
|
18/03/22
|
26/04/23
|
26/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
10.574
|
10.091
|
10.876
|
12.359
|
13.232
|
11.595
|
EBITDA
1 |
1.974
|
2.114
|
2.168
|
2.194
|
2.638
|
2.158
|
Bedrijfsresultaat (EBIT)
1 |
1.393
|
1.513
|
1.478
|
1.486
|
1.875
|
1.307
|
Operationele Marge
|
13,17%
|
14,99%
|
13,59%
|
12,02%
|
14,17%
|
11,27%
|
Resultaat voor belastingen (EBT)
1 |
1.074
|
1.149
|
1.165
|
1.286
|
1.623
|
892,4
|
Nettowinst (verlies)
1 |
511,3
|
620,2
|
651,7
|
670
|
433,3
|
302,1
|
Nettomarge
|
4,84%
|
6,15%
|
5,99%
|
5,42%
|
3,27%
|
2,61%
|
WPA
2 |
0,2500
|
0,3100
|
0,3300
|
0,3400
|
0,2188
|
0,1526
|
Free Cash Flow
1 |
372,9
|
-69,2
|
895,3
|
123,7
|
1.290
|
471,3
|
FCF-marge
|
3,53%
|
-0,69%
|
8,23%
|
1%
|
9,75%
|
4,06%
|
Kasstroomconversie (ebitda)
|
18,89%
|
-
|
41,29%
|
5,64%
|
48,91%
|
21,84%
|
Kasstroomconversie (nettowinst)
|
72,93%
|
-
|
137,37%
|
18,46%
|
297,81%
|
155,98%
|
Dividend per aandeel
2 |
0,2200
|
0,2200
|
0,2200
|
0,2200
|
0,2200
|
0,2200
|
Datum van publicatie
|
10/04/19
|
14/04/20
|
31/03/21
|
18/03/22
|
26/04/23
|
26/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
4.563
|
4.932
|
4.013
|
2.946
|
2.355
|
3.016
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,312
x
|
2,333
x
|
1,851
x
|
1,342
x
|
0,8928
x
|
1,397
x
|
Free Cash Flow
1 |
373
|
-69,2
|
895
|
124
|
1.290
|
471
|
ROE (netto-inkomsten/eigen vermogen)
|
6,27%
|
7,15%
|
6,54%
|
6,17%
|
6,96%
|
4,09%
|
ROA (netto-inkomsten/totale activa)
|
3,11%
|
3,54%
|
3,37%
|
3,19%
|
3,9%
|
2,69%
|
Totale activa
1 |
16.455
|
17.503
|
19.350
|
21.032
|
11.101
|
11.239
|
Nettoactief per aandeel
2 |
4,530
|
4,720
|
4,860
|
5,110
|
5,150
|
5,100
|
Cashflow per aandeel
2 |
2,170
|
1,700
|
2,080
|
2,220
|
2,110
|
1,910
|
Capex
1 |
1.099
|
1.433
|
1.231
|
1.256
|
1.131
|
1.284
|
Capex/omzet
|
10,4%
|
14,21%
|
11,32%
|
10,17%
|
8,55%
|
11,08%
|
Datum van publicatie
|
10/04/19
|
14/04/20
|
31/03/21
|
18/03/22
|
26/04/23
|
26/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -8,58% | 1,16 mld. | | +45,83% | 754 mld. | | +41,18% | 630 mld. | | -5,96% | 352 mld. | | +20,08% | 331 mld. | | +9,18% | 298 mld. | | +18,77% | 250 mld. | | +12,16% | 217 mld. | | -0,49% | 216 mld. | | +6,55% | 164 mld. |
Farmaceutische producten - Andere
|